πŸ‡ΊπŸ‡Έ FDA
Patent

US 9533966

Cyclic compounds

granted A61PA61P1/16A61P25/00

Quick answer

US patent 9533966 (Cyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P1/16, A61P25/00, A61P25/02, A61P29/00